Mesoblast Limited
MESOBiotechnology
$15.67+17.03%As of Oct 29vs prior close
- Market cap
- $2B
- P/E (TTM)
- –
- From 52W high
- −25.24%
- EPS (YE26)
- -$0.04
- Revenue (YE26)
- $120.3M
- Net margin
- -47.82%
- Dividend yield
- 0.00%
Nomior Score
49
Steady ProfileBottom 48% of the scored universe
Growth76
Quality63
Value—
Momentum27
Resilience36
Growth
+54.40%revenue a year over 9 fiscal years
YE17 $2.4MYE26 $120.3M
Connections
Revenue to profitYE26
The operating loss was 27% of revenue, narrower by 431 pts on a year.